Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...

Adults with cystic fibrosis experience higher pain prevalence and severity compared to healthy controls, with significant unmet needs in pain management. New study highlights critical gaps in care.

(AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central ...

Cystic fibrosis is a rare, life-shortening disease that affects over 90,000 people worldwide. It is caused by mutations in the CFTR ion channel, resulting in the aberrant flow of salt and water in ...

J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders FILE - The Johnson & Johnson headquarters in New Brunswick, New Jersey, on Feb. 8, 2024.

What is a cystic hygroma? A cystic hygroma — or lymphangioma — is a birth defect that appears as a sac-like structure with a thin wall that most commonly occurs in the head and neck area of an infant.

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Millions of people deal with acne, but those who suffer from cystic acne know how difficult it is to treat compared to ordinary pimples. Cystic acne is a severe form of acne that results in large ...